Navigation Links
Global Nuclear Medicine Market Report 2013-2017
Date:12/27/2013

DUBLIN, December 27, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/tn88ln/nuclear_medicine) has announced the addition of the "Global Nuclear Medicine Market Report 2013-2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lion's share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope. Furthermore, the PET market will witness a double digit growth during the forecast period.

The therapeutic segment contributes only 10% to the global radiopharmaceuticals market and I-131 has been considered as the gold standard for various oncology treatments in a combined therapy. Global nuclear medicines market is majorly driven by the increasing adoption of PET and SPECT scanners, and rising awareness for radiopharmaceuticals, whereas short half life of isotopes and stringent regulations are the factors that are hindering the growth of radiopharmaceuticals worldwide.

Besides highly preferred isotopes such as Tc-99m and F-18, significant growth is witnessed for Tl-201 and Rb-82 in diagnostic market and Y-90 and Lu-177 in beta therapy radioisotopes market. Exhaustive pipeline analysis reveals that coronary heart disease, Alzheimer's disease, breast cancer, and bone metastasis will drive the diagnostic radiopharmaceuticals market, whereas lymphoma, prostate cancer, bone metastasis, and hepatocellular carcinoma will boost the future of therapeutic radiopharmaceuticals. Besides new applications, the potential molecules that are expected to drive the market include Alpharadin (Ra-223), Ga-68, F-18 florbetapir, and F-18 choline. Though Ra-223 application is still under clinical trial, the market is highly optimistic regarding its clinical efficiency in prostate cancer, and bone metastasis.

Key Topics Covered:

1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology

2 Executive Summary

3 Market Overview
3.1 Definition Of Radiopharmaceuticals
3.2 Evolution
3.3 Market Segmentation
3.4 Market Dynamics
3.5 Winning Imperatives
3.6 Burning Issues
3.7 Market Share Analysis
3.8 Value Chain Analysis
3.9 Pipeline Analysis
3.10 Demand & Supply Analysis
3.11 Strategic Benchmarking
3.12 Regulatory Affairs

4 Global Radiopharmaceuticals Market, By Value
4.1 Introduction
4.2 Diagnostic Market
4.3 Therapeutic Market

5 Global Radiopharmaceuticals Market, By Procedural Volume
5.1 Introduction
5.2 Diagnostic Market
5.3 Therapeutic Market

6 Radiopharmaceuticals Market, By Application/Indication
6.1 Introduction
6.2 Diagnostic Market
6.3 Therapeutic Application

7 Enriched Stable Isotopes Market
7.1 Introduction
7.2 Market Overview
7.3 Market Dynamics
7.4 Enriched Stables Market, By Isotopes
7.5 Enriched Stables Market, By Applications

8 Geographic Analysis
8.1 Introduction
8.2 Diagnostic Market
8.3 Therapy Market
8.4 Enriched Stable Isotopes Market

9 Competitive Landscape
9.1 Introduction
9.2 Mergers & Acquisitions
9.3 Agreements, Partnerships, Collaborations & Joint Ventures
9.4 Products Launch
9.5 Expansions
9.6 Other Developments
9.7 Approvals

10 Company Profiles


Companies Mentioned:

  • Bracco Imaging SPA
  • Cambridge Isotope Laboratories, Inc
  • Cardinal Health, Inc
  • Covidien, Plc
  • Eczacibasi-Monrol
  • Fujifilm Holdings Corporation
  • Ge Healthcare (Subsidiary Of General Electric Company)
  • Iba Group
  • Isotec, Inc (Sigma-Aldrich)
  • Lantheus Medical Imaging, Inc
  • Nordion, Inc
  • Ntp Radioisotopes (PTY), Ltd
  • Petnet Solutions, Inc (A Subsidiary Of Siemens Medical Solutions Usa, Inc)
  • Rotem Industries, Ltd, Inc
  • Taiyo Nippon Sanso Corporation
  • Urenco Limited

For more information visit http://www.researchandmarkets.com/research/tn88ln/nuclear_medicine


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly ... announced actions to streamline operations to more efficiently ... improve its cost structure. Global workforce reductions, including ... are expected to impact approximately 3,500 positions. ... company expects annualized savings of approximately $500 million ...
(Date:9/7/2017)... 7, 2017 Caris Life Sciences, a ... the promise of precision medicine, today announced results ... of its molecular profiling approach in guiding therapeutic ... profiling plus (CGP+) with Caris Molecular Intelligence ® ... a molecular level, leading to more therapeutic options ...
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... Conference at the Grand Hyatt hotel in New York.  ... at 11:40 a.m. Eastern Time. A live ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .   ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic Trainers from ... Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, evidence based ... Trainers are acknowledged by their peers with accolades and highly prestigious awards. This ...
(Date:9/20/2017)... ... 2017 , ... Medicare doesn’t have the authority to negotiate ... their prescription drugs, according to a new comparison of drug plans by ... there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare policy ...
(Date:9/20/2017)... ... 20, 2017 , ... “Finn Mouseson”: follows the exciting story of a mouse ... mouse sets out on a journey that will show that friends are to be ... newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s degree in ...
(Date:9/20/2017)... ... ... “The Financial Favor of God; Second Edition”: a personal and exquisite recipe for ... of published author, Brooks Rathell. , “We typically hear about the favor of God. ... favor of God. Not only does it exist, but it is meant for you. ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, a ... leader, Denise Flannery, to its strategic advisory and client development team. , ... work with clients across different industries to develop and implement market-justified strategies, modernize ...
Breaking Medicine News(10 mins):